Case Details
- Citation: [2017] SGHC 53
- Title: National University Hospital (Singapore) Pte Ltd v Cicada Cube Pte Ltd
- Court: High Court of the Republic of Singapore
- Date of Decision: 14 March 2017
- Coram: Aedit Abdullah JC
- Case Number: Originating Summons No 239 of 2015
- Parties: National University Hospital (Singapore) Pte Ltd (Plaintiff/Applicant) v Cicada Cube Pte Ltd (Defendant/Respondent)
- Counsel for Plaintiff/Applicant: Tan Tee Jim, SC, Christopher de Souza, and Darrell Wee (Lee & Lee)
- Counsel for Defendant/Respondent: N Sreenivasan, SC, Andrew Heng and Ivan Qiu (Straits Law Practice LLC) and Jevon Louis (Ravindran Associates)
- Judges: Aedit Abdullah JC
- Legal Areas: Patents and Inventions — ownership; Patents and Inventions — employee’s invention
- Statutes Referenced: Patents Act (Cap 221, 2005 Rev Ed)
- Procedural History (editorial note): Appeals from this decision in Civil Appeals Nos 138 and 139 of 2016 were dismissed by the Court of Appeal on 28 August 2018 (see [2018] SGCA 52).
- Judgment Length: 28 pages, 14,468 words
- Inventors Named in the Patent: Dr Anil Kumar Ratty and Dr Danny Poo (founders/directors of Cicada)
- Inventors Claimed by NUH: Dr Sunil Kumar Sethi and Peter Lim (NUH employees)
- Patent Title: “Laboratory Specimen Collection Management System”
- Patent Filing and Grant: Filed 14 August 2007; granted 30 July 2010
- Key Relief Sought by NUH: (i) NUH to be named as sole and rightful proprietor; (ii) Dr Sethi and Peter Lim to be named as sole and rightful inventors (later, joint inventors/proprietor)
Summary
National University Hospital (Singapore) Pte Ltd v Cicada Cube Pte Ltd concerned a dispute over the ownership and recognition of inventorship of a patented process for collecting laboratory specimens. The registered proprietor of the patent was Cicada Cube Pte Ltd, and the named inventors were Cicada’s founders and directors, Dr Anil Kumar Ratty and Dr Danny Poo. NUH asserted that its own employees—Dr Sunil Kumar Sethi, a senior doctor and Chief of the Department of Laboratory Medicine, and Peter Lim, a Principal Medical Technologist—had contributed the inventive concept disclosed in the patent.
The High Court, presided over by Aedit Abdullah JC, approached the dispute as one centred on the “heart” of the invention: who contributed to the inventive concept(s) embodied in the patent. The court found that the invention comprised two distinct inventive concepts. It was persuaded that one inventive concept was contributed by Dr Sethi (though not by Peter Lim). However, NUH failed to prove that Dr Ratty and Dr Poo did not contribute to the other inventive concept. The court therefore ordered that Dr Sethi, Dr Ratty, and Dr Poo be named as joint inventors, and that NUH be named as a joint proprietor together with Cicada.
What Were the Facts of This Case?
NUH was a Singapore-incorporated tertiary hospital. Until 2008, it was part of the National Healthcare Group (NHG). From 2008, it became part of the National University Health System. At the material time, Dr Sethi served as Chief of NUH’s Department of Laboratory Medicine from 1 July 2002 to 31 March 2016. Peter Lim was NUH’s Principal Medical Technologist at the relevant time. Their roles placed them at the centre of laboratory medicine workflows, including specimen testing processes and the practical requirements for safe and efficient specimen collection.
Cicada Cube Pte Ltd was founded by Dr Ratty and Dr Poo, who were directors of Cicada at the material time. The dispute arose against the backdrop of a broader healthcare digitisation initiative. In 2004, NHG embarked on a project to digitise clinical care processes in its hospitals, including NUH. At that time, laboratory tests ordered by doctors were performed using hardcopy forms and then keyed into an electronic system known as the Laboratory Information System (LIS). The digitisation plan contemplated an Electronic Medical Records (EMR) system with Computerised Physician Order Entry (CPOE) capability, enabling doctors to order laboratory tests electronically.
NUH’s position was that, even after EMR implementation, an additional component was needed to create a complete electronic laboratory trail from test ordering through to result reporting. NUH decided to develop software to manage specimen collection and related workflows. One workflow requiring translation into code was the printing of test tube labels when specimens were taken from patients and the registration of specimens to the LIS. Cicada was appointed by NUH to develop software under a project called the Advanced Test Ordering Management System (ATOMS).
Because NUH lacked sufficient funds for the ATOMS project, Cicada applied for external funding through the Prime Minister’s Office under the Enterprise Challenge (TEC) programme. A tripartite agreement was entered between Cicada, NHG, and the PMO, allowing Cicada to leverage NUH’s expertise and resources to conduct pilot trials of ATOMS. The patent at the centre of the dispute was filed by Cicada on 14 August 2007 and granted by IPOS on 30 July 2010. The patent was titled “Laboratory Specimen Collection Management System” and named Dr Ratty and Dr Poo as inventors.
What Were the Key Legal Issues?
The principal legal issues were (1) who the true inventors were for the invention disclosed in the patent, and (2) who was the rightful proprietor of the patent as a consequence of inventorship and ownership principles under Singapore patent law. Although the patent was registered in Cicada’s name, NUH sought to displace the registered proprietor and to correct the inventors named in the patent register.
At the heart of the dispute was the determination of inventive contribution—specifically, who contributed to the inventive concept, described in the judgment as the “heart” of the invention. The court had to evaluate competing narratives: Cicada argued that its officers developed the invention through brainstorming and practical software engineering work, while NUH argued that its employees, particularly Dr Sethi and Peter Lim, developed the idea based on years of medical testing experience and knowledge of laboratory specimen collection requirements.
A further issue concerned the legal consequences of employee involvement in an invention. The case fell within the broader category of “employee’s invention” disputes, where the law requires careful analysis of whether and how an employee’s contribution amounts to inventorship, and how that affects ownership. The court’s task was not merely to decide who worked on the project, but to identify who made the inventive contribution(s) to the claimed subject matter.
How Did the Court Analyse the Issues?
The court’s analysis began with the patent disclosure itself. The specification described the invention as a laboratory specimen collection management system for clinical laboratories, particularly a system to identify the type and number of tubes to use and to facilitate specimen collection at the point of care. The specification identified problems with existing specimen collection systems: (a) specimen takers had to determine tube types, number of tubes, and amounts based on experiential knowledge and charts, making the process tedious and error-prone; (b) non-standard pre-generated labels could lead to mix-ups and wrong patient identification; and (c) two labels per tube were required—one at point of collection and another at the laboratory—making the process time-consuming and inefficient.
The court then examined the claimed solution as described in the patent. The invention comprised specimen collection stations at the point of care coupled to a specimen processing system. The specimen processing system contained business logic for determining specimen requirements, including tube type, number of tubes, colour code, and specimen amount, and it was coupled to a database containing analyser test accession numbers. The collection stations included a user interface device, a hand-held scanner or data input device, a processing unit, and a printer. Patients were identified and verified electronically via the scanner, and the doctor’s ordered tests were displayed graphically to inform the specimen taker of requirements. Crucially, the system printed labels in situ so that only one label needed to be affixed to each tube, reducing label mix-ups.
Against this technical and functional framework, the court evaluated evidence about who contributed to the inventive concept(s). The judgment emphasised that inventorship turns on inventive contribution to the “heart” of the invention, not on who was involved in the project generally or who implemented ideas. The court found that the invention embodied two inventive concepts. This finding was significant because it allowed the court to allocate inventorship and ownership contributions across different aspects of the disclosed system rather than treating the invention as a single monolithic concept.
On the evidence, the court was persuaded that one inventive concept was contributed by Dr Sethi, although not by Peter Lim. This suggests that Dr Sethi’s contribution related to a particular inventive element within the overall system—likely tied to the clinical workflow knowledge and requirements that shaped the inventive logic or operational design. However, NUH did not succeed in proving that Dr Ratty and Dr Poo did not contribute to the other inventive concept. The court therefore concluded that Dr Ratty and Dr Poo were also inventors for that other aspect of the invention.
In practical terms, the court treated the burden of proof as decisive. NUH bore the burden of demonstrating that the registered inventors were not the true inventors for the relevant inventive concept(s). While NUH succeeded in establishing Dr Sethi’s contribution to one inventive concept, it failed to discharge the burden regarding the other inventive concept. The court’s approach reflects a careful evidential standard: where inventorship is disputed, the claimant must show not only that their employees were involved, but that they made the inventive contribution that the patent claims.
Finally, the court translated inventorship findings into ownership outcomes. The patent was registered in Cicada’s name. However, where an employee’s inventive contribution is established, ownership may be shared depending on the legal framework and the nature of the contribution. The court ordered that NUH be named as a joint proprietor together with Cicada, reflecting the conclusion that NUH’s employee, Dr Sethi, was a joint inventor and that NUH therefore had a proprietary interest in the patent corresponding to that contribution.
What Was the Outcome?
The High Court ordered that Dr Sethi, Dr Ratty, and Dr Poo be named as joint inventors of the invention disclosed in the patent. It further ordered that NUH be named as a joint proprietor of the patent together with Cicada. This was a partial victory for NUH: NUH did not obtain sole inventorship or sole proprietorship, but it succeeded in correcting the register to reflect joint inventorship and joint ownership.
Both parties were dissatisfied and appealed. The editorial note indicates that the appeals were dismissed by the Court of Appeal on 28 August 2018 (see [2018] SGCA 52). Accordingly, the High Court’s allocation of inventorship and joint proprietorship remained the final position.
Why Does This Case Matter?
This case is important for patent disputes in Singapore because it illustrates how courts approach inventorship in collaborative, multi-disciplinary projects—particularly where clinical expertise and software engineering intersect. The court’s identification of two inventive concepts demonstrates that inventorship may not be an all-or-nothing determination. Instead, where different contributors make inventive contributions to different aspects of the claimed subject matter, the law may recognise joint inventorship.
For practitioners, the decision underscores the evidential burden on the party seeking to correct the patent register. NUH succeeded in proving Dr Sethi’s contribution to one inventive concept, but failed to prove the negative proposition that Dr Ratty and Dr Poo did not contribute to the other inventive concept. This highlights that a claimant must marshal evidence that directly addresses inventive contribution to the “heart” of the invention, rather than relying on general involvement, employment roles, or assumptions about who “came up with the idea.”
The case also has practical implications for technology development agreements between hospitals and vendors. Where external vendors are engaged to develop software based on clinical workflows, parties should ensure that inventorship and ownership are addressed contractually and that documentation exists to support the attribution of inventive contributions. The court’s reasoning suggests that contemporaneous records, clear delineation of responsibilities, and careful articulation of what constitutes the inventive concept(s) can be crucial in later disputes.
Legislation Referenced
Cases Cited
- [1992] SGHC 113
- [2017] SGHC 53
- [2018] SGCA 52
Source Documents
This article analyses [2017] SGHC 53 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.